From data in patients with ARDS and treatment with veno-venous ECMO, it is known that decreases of plasma concentrations of Hp within the first week of treatment with ECMO were associated with an increased 28-day mortality [53]. The gene discussed is HP; the disease is acute respiratory distress syndrome.